Medical/Pharmaceuticals
Technology Solutions to Boost Employee Experience and Improve Patient Outcomes
Workforce management solutions from DXC and SAP support healthcare providers in managing their teams while focusing on employees' well-being and ability to deliver quality care SAN ANTONIO, Aug. 3, 2022 /PRNewswire/ -- Healthcare providers may find that supporting their care team and managing th...
2022-08-03 15:12
2881
Yidu Tech Releases FY2022 ESG Report, Using Socially Beneficial Technology to Drive the Sustainable Development of "Green Healthcare"
HONG KONG, Aug. 3, 2022 /PRNewswire/ -- The digital economy powered by innovative technologies such as artificial intelligence ("AI") and big data has become one of the most powerful drivers of economic growth since the COVID-19 outbreak, in keeping withChina's core strategy of "digitalization, ...
2022-08-03 15:09
3393
Vela Diagnostics Supports COVID-19 Surveillance Efforts in Kenya
HAMBURG, Germany, Aug. 3, 2022 /PRNewswire/ -- Vela Diagnostics has announced its appointment by the National Public Health Laboratory ofKenya (NPHL) as their supplier for SARS-CoV-2 genotyping tests, with funding from The Global Fund. The NPHL operates under Kenya's Ministry of Health and plays...
2022-08-03 14:00
2858
Lim Chin Hau and Medicap Sdn Bhd Awarded at the Asia Pacific Enterprise Awards 2022 Malaysia
KUALA LUMPUR, Malaysia, Aug. 3, 2022 /PRNewswire/ -- Enterprise Asia, the organizer of the 13th Asia Pacific Enterprise Awards (APEA) 2022 Malaysia, is pleased to recognize 47 exceptional business leaders and enterprises that have played a vital role in shapingMalaysia's entrepreneurial landscape...
2022-08-03 13:12
3606
Approval Of The Comparative Study Between ReCOV And mRNA Vaccines By FDA In The Philippines
TAIZHOU, China, Aug. 3, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the"Company", together with its subsidiaries, the "Group",Stock code:02179.HK) is pleased to announce that, the Company has recently received the clinical trial approval for its recombinant protein COVID-19 vaccine,...
2022-08-03 13:09
5090
Antengene Announces First Patient Dosed in the PROBE-CN Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma
* ATG-101 is a novel PD-L1/4-1BB bispecific antibody. It is Antengene's first in-house developed molecule with global rights. * ATG-101 demonstrates potent in vivo efficacy in anti-PD-1/PD-L1 resistant mouse tumor models. SHANGHAI and HONG KONG, Aug. 3, 2022 /PRNewswire/ -- Antengene Corpora...
2022-08-03 08:30
3093
Sciwind Biosciences Announces Positive Topline Results from 20-week Phase 2 Clinical Trial of XW003 (Ecnoglutide), a novel long-lasting GLP-1 analogue, in Adult Patients with Type 2 Diabetes in China
- Robust HbA1c reduction of 2.4% was observed with 1.2 mg XW003 dose - Up to 88% of participants achieved HbA1c ≤ 7% and up to 72% achieved HbA1c ≤6.5% at the end of the 20-week treatment - XW003 was safe and well tolerated with gastrointestinal side effects as the most commonly reported adve...
2022-08-03 08:00
3779
Lynk Pharmaceuticals Announces IND Approval of LNK01004 for Atopic Dermatitis in China
HANGZHOU, China, Aug. 3, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that its innovative drug LNK01004, has been approved by National Medical Products Administration (NMPA) for clinical tr...
2022-08-03 08:00
4099
Ablaze Pharma Aligned The Strategic Agreement With Wenjiang District Government of Chengdu to Build-up the Innovative R&D and Manufacturing Center for Targeted Radiopharmaceutical Therapies
SHANGHAI, Aug. 3, 2022 /PRNewswire/ -- In July 2022, Ablaze Pharma and Wenjiang District Government ofChengdu jointly signed the strategic agreement during the Conference of Major Advanced Manufacturing Projects by Foreign Direct Investment. About 26,000㎡ of industrial land is selected in the Che...
2022-08-03 08:00
3516
LOWER SOCIOECONOMIC STATUS IN CHILDHOOD, PERSISTENT LOW WAGES LINKED TO RISK FOR DEMENTIA AND FASTER MEMORY DECLINE
SAN DIEGO, Aug. 3, 2022 /PRNewswire/ -- Socioeconomic deprivation, including neighborhood disadvantages and persistent low wages, are associated with higher dementia risk, lower cognitive performance and faster memory decline, according to several studies reported today at theAlzheimer's Associat...
2022-08-03 00:15
4762
Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination
Preclinical data support the potential of ONA-XR plus estrogen receptor degraders in endocrine resistant disease models Context to initiate Phase 1b/2 clinical trial in Q4 2022 PHILADELPHIA and FLORENCE, Italy, Aug. 2, 2022 /PRNewswire/ -- Context Therapeutics Inc. ("Context" or the "Company") (...
2022-08-02 22:49
4963
Metabolon Awarded ISO 9001:2015 Recertification
ISO 9001:2015 certificate re-issued to Metabolon following continued demonstrated ability to meet customer, statutory, and regulatory standards MORRISVILLE, N.C., Aug. 2, 2022 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance drug development and ...
2022-08-02 20:57
2245
Sironax Announces Closing of $200 Million Series B Financing
Financing from new and existing investors will support pipeline progression and expansion for age-related degenerative diseases BEIJING, Aug. 2, 2022 /PRNewswire/ -- Sironax, an emerging biotechnology company dedicated to the discovery and global development of novel treatments for patients with...
2022-08-02 19:00
3716
Dr Ivan Puah Recommends Fat Grafting As A Solution Following Post-surgery Scars or Disfigurement
Fat grafting is highly recommended as part of the corrective surgery method to correct facial or body disfigurement from liposuction, laparoscopy or surgeries that cause dents and irregular contours. SINGAPORE, Aug. 2, 2022 /PRNewswire/ -- Dr Ivan Puah, Medical Director at Amaris B. Clinic,...
2022-08-02 16:41
3214
Pharming Announces New ICD-10-CM Code for APDS, a Rare Primary Immunodeficiency
Implemented by the Centers for Disease Control and Prevention, the diagnosis code will accurately identify US patients with APDS, supporting care and research efforts LEIDEN, Netherlands, Aug. 2, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Na...
2022-08-02 13:00
3995
Advanced Instruments Acquires SAL Scientific, Expertise, and a Range of Cell Growth Supplements in Support of Research & Drug Discovery Workflows
NORWOOD, Mass., Aug. 2, 2022 /PRNewswire/ -- Advanced Instruments, a leading manufacturer of analytical instruments and services for bioprocessing, today announced the acquisition of SAL Scientific Ltd., a private company that develops and manufactures a portfolio of cell growth supplements for C...
2022-08-02 10:28
3397
GenKOre develops hypercompact adenine base editors (ABEs)
DAEJEON, South Korea, Aug. 2, 2022 /PRNewswire/ -- GenKOre, a biotech start-up
in Korea, succeeded in the development of ABEs based on its own hypercompact
gene-editing technology and had the relevant study published on Nature Chemical
Biology onAugust 2, 2022.
2022-08-02 09:07
3644
AVer Introduces Revolutionary Detachable Medical Grade Cameras
NEW TAIPEI CITY, Taiwan, Aug. 2, 2022 /PRNewswire/ -- AVer Information Inc., the award-winning provider of video collaboration and education technology solutions, is excited to introduce its Connected Health Solutions, which was created from AVer's dedication in understanding and contributing to ...
2022-08-02 09:00
3507
Novel and fast typing method developed to control monkeypox by Molecular Biology Systems (MBS) in collaboration with the Amsterdam UMC and Danish Rigshospitalet
GOES, Netherlands, Aug. 2, 2022 /PRNewswire/ -- In the worldwide effort to control monkeypox, a novel and fast typing method to trace monkeypox virus strains was developed by Dutch company Molecular Biology Systems (MBS) in collaboration with the department of Medical Microbiology & Infectious Di...
2022-08-02 08:00
3415
Kira Pharmaceuticals Appoints Angela Yan as President of China and Asia Development and Operations
CAMBRIDGE, Mass. and SUZHOU, China, Aug. 2, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global clinical-stage biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced the appointment ofAngela (Hui) Yan as President of China and Asi...
2022-08-02 07:00
4856
Week's Top Stories
Most Reposted
TD Brings its Global Asset Management Businesses Under One Name
[Picked up by 1168 media titles]
2026-11-02 20:00OceanaGold Reports Third Quarter 2026 Results
[Picked up by 1129 media titles]
2026-11-05 06:52Overstory Launches Integrated AI Platform to Deliver First Living Model of Grid Risk
[Picked up by 1082 media titles]
2026-11-03 22:00Fintech OPay Raises $304 Million Ahead of NYSE Debut: NYSE Content Update
[Picked up by 1079 media titles]
2026-10-30 22:34
H.E. Ahmed Al-Khateeb, Saudi Minister of Tourism, Inaugurates Saudi Land at WTM London 2026, Reinforcing Saudi's Commitment to Global Travel Trade
[Picked up by 1067 media titles]
2026-11-04 07:31
Most Read
1B views since June: Coda and TikTok Gaming turn content into commerce
2026-11-02 09:35
60454
Airbrush Upgrades AI Image Enhancer With 16K Output and Batch Processing for Up to 50 Images
2026-11-03 02:00
55740
iQIYI Launches China's First AI Film Studio in Shanghai, with Inaugural Title "Cop in Trouble" in Production
2026-11-02 09:52
53501
Korean Derma Skincare Brand MDP+ Launches at Nordstrom
2026-11-03 00:30
22954
